Approximately 50% of pregnant individuals treated for syphilis do not achieve a decline in non-treponemal titers by delivery. The serological response in pregnant persons is significantly slower compared to non-pregnant individuals, with unclear pathogenesis and clinical significance. This study aimed to determine the association between the host immune response and serological outcome in pregnant individuals with syphilis.
Methods
Twenty-four females with early syphilis, including 14 pregnant individuals, were included. Pro-inflammatory and regulatory cytokines (IFN-γ, TNF-α, IL-4, IL-1β, IL-10, TGF-β) were measured before treatment and 6 months after penicillin injection.
Results
The median time to serological cure was 5 months for pregnant individuals and 2 months for non-pregnant females. Pregnant individuals had significantly higher serum levels of IL-10 and TGF-β at baseline and at 6 months post-treatment compared to non-pregnant individuals (p < .05).
Conclusions
A robust regulatory immune response to syphilis may be associated with a slower serological response to therapy during pregnancy.
KojimaNKlausnerJD. An update on the global epidemiology of syphilis. Curr Epidemiol Rep2018; 5(1): 24–38. DOI: 10.1007/s40471-018-0138-z.
2.
GiakoumelouSWheelhouseNCuschieriK, et al.The role of infection in miscarriage. Hum Reprod Update2016; 22: 116–133.
3.
D’AiutoCValderramaAByrnsM, et al.Sexually transmitted and blood-borne infections in pregnant women and adverse pregnancy outcomes. J Obstet Gynaecol Can2020; 42(8): 977–983. DOI: 10.1016/j.jogc.2020.01.023.
4.
Centers for Disease Control and Prevenation. Sexually transmitted diseases treatment guidelines 2021. Atlanta, GA: US Department of Health and Human Services, 2021.
5.
CaoQLiYHuY, et al.Serofast status in syphilis: pathogenesis to therapeutics. Clin Chim Acta2024; 560: 119754. DOI: 10.1016/j.cca.2024.119754.
6.
GalanHLMontalvoJFDeaverJ. Retrospective analysis of the serologic response to the treatment of syphilis during pregnancy. Infect Dis Obstet Gynecol1997; 5(1): 23–28. DOI: 10.1155/S1064744997000070.
7.
RacMWBryantSNCanteyJB, et al.Maternal titers after adequate syphilotherapy during pregnancy. Clin Infect Dis2015; 60(5): 686–690. DOI: 10.1093/cid/ciu920.
8.
PastuszczakMGozdzialskaAJakielaB, et al.Robust pro-inflammatory immune response is associated with serological cure in patients with syphilis: an observational study. Sex Transm Infect2017; 93(1): 11–14. DOI: 10.1136/sextrans-2016-052681.
9.
ZhouPGuXLuH, et al.Re-evaluation of serological criteria for early syphilis treatment efficacy: progression to neurosyphilis despite therapy. Sex Transm Infect2012; 88(5): 342.
10.
SeñaACZhangXHLiT, et al.A systematic review of syphilis serological treatment outcomes in HIV-infected and HIVuninfected persons: rethinking the significance of serological nonresponsiveness and the serofast state after therapy. BMC Infect Dis. 2015 Oct 28;15:479.
11.
MorGCardenasI. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol2010; 63: 425–433.
12.
HarmonACCorneliusDCAmaralLM, et al.The role of inflammation in the pathology of preeclampsia. Clin Sci2016; 130: 409–419.
Gayet-AgeronALautenschlagerSNinetB, et al.Sensitivity, specificity and likelihood ratios of PCR in the diagnosis of syphilis: a systematic review and meta-analysis. Sex Transm Infect2013; 89: 251–256.
CruzARRamirezLGZuluagaAV, et al.Immune evasion and recognition of the syphilis spirochete in blood and skin of secondary syphilis patients: two immunologically distinct compartments. PLoS Neglected Trop Dis2012; 6: e1717.
17.
TongMLLinLRLiuGL, et al.Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent and tertiary syphilis. PLoS One2013; 8: e70102.
18.
BabolinCAmedeiAOzolinsD, et al.TpF1 from Treponema pallidum activates inflammasome and promotes the development of regulatory T cells. J Immunol2011; 187: 1377–1384.
19.
DragoFJavorSParodiA. Relevance in biology and mechanisms of immune and treatment evasion of Treponema pallidum. G Ital Dermatol Venereol2019; 154: 573–580.
20.
SaraivaMO’GarraA. The regulation of IL-10 production by immune cells. Nat Rev Immunol2010; 10: 170–181.
21.
MedinaTSCostaSPOliveiraMD, et al.Increased interleukin-10 and interferon-g levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism. Malar J2011; 14: 264.
22.
ReedSGBrownellCERussoDM, et al.IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol1994; 153: 3135–3140.
23.
RoqueSNobregaCAppelbergR, et al.IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. J Immunol2007; 178: 8028–8035.
24.
ClericiMWynnTABerzofskyJA, et al.Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest1994; 93: 768–775.
25.
AccepezzatoDFrancavillaVParoliM, et al.Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest2004; 113: 963–972.
26.
LiKWangCLuH, et al.Regulatory T cells in peripheral blood and cerebrospinal fluid of syphilis patients with and without neurological involvement. PLoS Neglected Trop Dis2013; 7: e2528.
27.
PastuszczakMJakielaBJaworekAK, et al.Association of interleukin-10 promoter polymorphisms with neurosyphilis. Hum Immunol2015; 76: 469–472.
28.
HannaNJBambangKKaitu’u-LinoTJ, et al.A bioplex analysis of cytokines and chemokines in first trimester maternal plasma to screen predictors of miscarriage. PLoS One2014; 9: e93320.
29.
MakrisAXuBYuB, et al.Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta2006; 27: 445–451.
30.
NathanLBohnanVLSanchezPJ, et al.In utero infection with Treponema pallidum in early pregnancy. Pregnat Diagn1997; 17: 119–123.
31.
DondersGGDesmyterJHooftP, et al.Apparent failure of one injection of benzathine penicillin G for syphilis during pregnancy in human immunodeficiency virus-seronegative African women. Sex Transm Dis1997; 24: 94–101.
